You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
On demand events

EAACI 2022 | Pediatric Asthma Symposium | Redefining Pediatric Severe Asthma and the Future of Clinical Management

Join Drs. Leonard Bacharier and Wanda Phipatanakul as they discuss the future of clinical management in severe pediatric asthma.

Leonard Bacharier
Wanda Phipatanakul
Leonard Bacharier +1 more

On demand materials

Learning objectives

  • Define pediatric severe asthma as a type 2 inflammatory disease driven by key and central cytokines, IL-4 and IL-13
  • Understand the clinical burden of pediatric severe asthma on both the children and their caregivers
  • Evaluate the role of biomarkers in pediatric severe asthma
  • Understand the latest management guidelines for pediatric severe asthma and the importance of recognizing type 2 inflammation in treatment decision-making
  • Evaluate the latest biologic evidence of reduced exacerbations, improved lung function, asthma control and quality of life in pediatric severe asthma patients

About these experts